Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2021)

Historic Treasury Shares for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q3 2021 value amounting to $30667.0.

  • Black Diamond Therapeutics' Treasury Shares fell 4831.46% to $30667.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $30667.0, marking a year-over-year decrease of 4831.46%. This contributed to the annual value of $18120.0 for FY2020, which is N/A changed from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Treasury Shares of $30667.0 as of Q3 2021, which was down 4831.46% from $51007.0 recorded in Q2 2021.
  • Black Diamond Therapeutics' 5-year Treasury Shares high stood at $132645.0 for Q4 2018, and its period low was $18120.0 during Q4 2020.
  • Its 3-year average for Treasury Shares is $58518.5, with a median of $55170.5 in 2020.
  • Within the past 5 years, the most significant YoY rise in Black Diamond Therapeutics' Treasury Shares was 4831.46% (2021), while the steepest drop was 4831.46% (2021).
  • Over the past 3 years, Black Diamond Therapeutics' Treasury Shares (Quarter) stood at $132645.0 in 2018, then plummeted by 86.34% to $18120.0 in 2020, then surged by 69.24% to $30667.0 in 2021.
  • Its Treasury Shares stands at $30667.0 for Q3 2021, versus $51007.0 for Q2 2021 and $59338.0 for Q1 2021.